Synapticure Secures $25M To Scale Virtual Care for Neurodegenerative Diseases
Synapticure, a virtual care company focusing on neurodegenerative diseases, has raised $25…
Four-in-ten first-time HIV diagnoses found late
In 2023, there was a 15% decrease in new HIV diagnoses in…